Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers
Supplement Fluid & Collagen Deposition
1 other identifier
interventional
63
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether providing extra fluid to nursing home residents will help prevent or heal pressure ulcers. We hypothesize that providing extra fluid to nursing home residents will increase their skin blood flow and oxygen to support healing and maintaining healthy skin. Participants are enrolled who have a pressure ulcer or who are at-risk for an ulcer (determined by looking at risk factors). The study is divided into two 10 day phases. In Phase 1, we examine participant's usual status, including fluid intake and baseline healing potential. In Phase 2, participants are randomly placed in groups to receive either their usually prescribed fluid intake or additional fluid. A study nurse provides the fluid to the residents. We measure their actual intake, their body water, how well their kidneys are working, their potential to heal, and also monitor them for the development of fluid overload. This study is important because it helps us understand the role of a basic nursing intervention in the prevention and treatment of pressure ulcers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2003
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 24, 2007
CompletedFirst Posted
Study publicly available on registry
July 26, 2007
CompletedMarch 6, 2015
March 1, 2015
July 24, 2007
March 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Collagen deposition
10 days
Secondary Outcomes (2)
Total body water
10 days
Safety - development of heart failure
Study duration
Study Arms (2)
Prescribed
ACTIVE COMPARATORFluid volume and type prescribed by MD or provider.
Supplemental
EXPERIMENTALFluid volume and type prescribed by physician or provider plus 10 ml/kg X 5 days.
Interventions
Volume of fluid prescribed by physician or provider/day X 5 days.
Fluid volume and type prescribed by physician or provider plus 10 ml/kg/day X 5 days.
Eligibility Criteria
You may qualify if:
- Persons age =/\> 60 years at risk for pressure ulcers (Braden Scale score \<18 or nonblanchable erythema \[Stage 1 ulcer\]) or with a Stage II-IV pressure ulcer and WBC of at least 2,000/mm3
You may not qualify if:
- Those:
- Who have or have had heart failure or renal failure/insufficiency
- Who currently smoke
- With acute illness or having experienced it in the last 7 days
- Taking immunosuppressive drugs
- With an implantable defibrillator
- With a glycosylated hemoglobin of \>8%
- With a body mass index is \<21 kg/m2 or \> 30 kg/m2; and
- Being treated for dehydration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy A. Stotts, RN, EdD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2007
First Posted
July 26, 2007
Study Start
September 1, 2003
Study Completion
March 1, 2007
Last Updated
March 6, 2015
Record last verified: 2015-03